RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 2:42 AM
Followers: 439
Posts Today: 1
Views Today: 66353

CYDY Stock Quote & Tools

$0.2054 ▲ +0.0054 (+2.69%) As of Oct 15, 3:59 PM EDT
Last0.2054
$ Chg0.0054
Open0.2000
High0.2090
Beta1.4964
Year High0.397
Market Cap301.80M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.57M
Volume3.28M
% Chg+2.69%
Prev Close0.2000
Low0.1971
VWAP0.20198
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. CTMedic

    smurph, I just finished reading the description of the MOA. I was thinking remodeling/repair of

  2. smurph

    CTMedic - NYHA class II - Slight limitation of physical activity, in which ordinary physical

  3. CTMedic

    Smurph, That is tremendously exciting news. Death from congestive heart failure is typically an

  4. ohm20

    Proven safe and may be effective are right out of the EUA guidelines.

  5. ohm20

    I wasn't aware. I just took a look at it and it's exactly what I told my friend.

  6. smurph

    Head of FDA Stephen Hahn, Commissioner Oct. 2020 Now, you and I, I think we both would agree

    (2)
  7. otcaddict

    I dont think NP knows more than you do since you have so much BP information. Maybe you should tell

    (3)
  8. smurph

    Chronic heart failure/disease -anybody here/friends got it ? Maybe this will help. News came out

    (4)
  9. calstang

    The FDA has made critical, ignorant, deadly decisions to not alter their strict protocol to adapt

    (2)
  10. calstang

    "The situation in 2 months is going to be extremely desperate." No, the situation is extremely

    (2)
  11. CDiddy

    Knock it off. You know he can't buy on inside info.

    (9)
  12. jeff67

    Hate to disagree with this but you are looking forward to innovation from the government which is

    (3)
  13. jeff67

    If the FDA follows Steve Hahns guidelines you just mentioned, the answer is yes. The question is

    (3)
  14. CTMedic

    Calstang, That is my belief with trial completion. I believe based on the stats by Techguru and

  15. calstang

    "May be effective" and "has been shown to be safe" (lives may be saved) Wouldn't the above FDA

    (1)
  16. calstang

    This is still confusing, (Cytodyn seeing s/c data) understandably so, since it is complex with alot

    (1)
  17. MD VIROLOGIST

    You are right, in response, to another question LL was not tagged.

  18. CTMedic

    Havasu, I don't recall that, but I certainly have not seen all of Dr. Patterson's interviews.

  19. havasu78

    I remember Patterson saying many months ago that he was running receptor occupancy on CD12 and CD10

  20. CTMedic

    Havasu, I don't believe that receptor occupancy is part of the CD12 trial any more than viremia.

    (1)
  21. CTMedic

    Ohm20, I'm sure you already aware, but the CDC vaccine FAQs explicitly address the question of

  22. havasu78

    CYDY has ALWAYS BEEN UNBLINDED on CD12?!?!?!? That post is way beyond an "interesting read".

    (2)
  23. Shelly2626

    Excellent Synopsis Thanks !!!

  24. ohm20

    I spent nearly an hour last week explaining mRNA vaccines Yesterday I had to exp

    (2)
  25. mtruong34

    Exactly! Thank you! All these guys thinking the "easy to calcuate mortality top line results"

    (2)
  26. CTMedic

    ClosetInvestor, I am glad to hear you have taken time to explain the vaccines to your patients.

    (3)
  27. CTMedic

    A not so brief reminder of what the DSMB does and why the actions of the DSMB for Cytodny CD 12 are

    (27)
  28. ohm20

    Mid-February is what I had pegged for approval also.

    (4)
  29. reallypeople?

    Thanks for reply . Some back ground on my contact . Obviously someone different I have been

    (1)
  30. ClosetInvestor

    I hope the same does not occur for leronlimab. The vaccine became a political subject/tool,

    (1)
  31. MD VIROLOGIST

    Plus not all PI's are prompt and it there is major differences between study sites that could also

    (1)
  32. jeff67

    This is why I believe many investors in Cydy right now have very aggressive dates for EUA. I

  33. Enjay

    reallypeople? The poster is Science + Compliance He recently added the following: I have

    (1)
  34. CTMedic

    MD Virologist, Thanks for reminding us of that. I would say more generally that there are still

  35. reallypeople?

    Who was the poster on yahoo ?? I have communicated with a expert in these matters over there .

    (1)
  36. MD VIROLOGIST

    This not a bash or coming from a shorter. Just a reminder that when Pfiizer and Moderna (big

    (3)
  37. onestepahead

    Yup weve seen this act before from the shorts OMG we havent heard anything must be

    (2)
  38. onestepahead

    Good read- Many shorts are going to end up like these shorts deeper And deeper in the hole Looking

    (1)
  39. ClosetInvestor

    Theres always an excuse why NP has never purchased a share on the open market, even when,

    (6)
  40. MarcS

    This is the final time I will mention this here, but the date they finished over-enrollment of

    (9)
  41. ClosetInvestor

    Thanks for posting the response. What Im saying is the lab data with the secondary endpoints

    (4)
  42. CDiddy

    Lol. I have more confidence that I deserve. Good question on OWS. They may not even be needed

    (2)
  43. thriftycents

    I have confidence to spare if you want to borrow some. :-) In all seriousness though, if it

  44. LaundryMoney

    Lets not forget scheduling a BTD cancer meeting with the FDA...also supposed to come this month,

    (1)
  45. grow

    FWIW the PR says enrollment completed December 15 which is a day earlier than what you mention.

  46. CDiddy

    It could be. Im just not overly confident, not concerned about uplisting. It will happen when

  47. thriftycents

    You forgot to mention uplisting will be announced which will keep us busy for a few weeks while

    (2)
  48. CaptnAmerca

    Absolutely. We are going to be in for at least a week or two of "the data should have been

    (2)
  49. CDiddy

    To add to this, I think the shorts may be pushing the idea of fast data, so that when it isn't fast

    (10)
  50. CDiddy

    First we will hear that the 28th day has been reached, and we hope to compile and lock the data

    (7)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

HTX Launches Anniversary Campaign with $80,000 in Rewards

Updated Category News Views 122

HTX Celebrates 12 Years with Exciting Trading Competitions PANAMA CITY — To honor its 12th anniversary, HTX, a prominent player in the cryptocurrency exchange landscape, is excited to unveil two major trading campaigns. The campaigns are titled the Margin Loan & Trading Dual Challenge and the Hot Crypto Futures Trading Challenge. Together, they provide a total prize...

Continue Reading
Insights on Rathbones Group Plc and Balanced Property Trust

Updated Category News Views 108

Understanding Recent Disclosures by Rathbones Group Plc In the world of finance and investments, transparency is crucial. Recently, Rathbones Group Plc made public disclosures under the regulations governing market transactions, particularly concerning its interests in Balanced Commercial Property Trust Limited. This disclosure is significant as it not only reflects...

Continue Reading
TheSushiDragon Partners with StreamerDap to Empower Creators

Updated Category News Views 285

TheSushiDragon Joins StreamerDap as Co-Owner In a groundbreaking move for the live streaming community, TheSushiDragon, a prominent Twitch creator, has officially entered an equity partnership with StreamerDap, a leading platform revolutionizing the sponsorship landscape for creators. This innovative partnership aims to enhance the creator experience, making sponsorships...

Continue Reading
Understanding the Recent Trends in CACI International's Short Interest

Updated Category News Views 53

Exploring CACI International's Short Interest Trend CACI International (NYSE: CACI) has recently seen a notable rise in its short percent of float, now standing at 10.26% since the last report. Currently, there are 169 thousand shares sold short, equating to 0.86% of all regular shares available for trading. Significance of Short Interest Understanding short interest is...

Continue Reading
Instem Unveils Innovative Cloud Solution for Pathology Management

Updated Category News Views 115

Innovative Pathology Module for Efficient Research Instem has recently introduced its groundbreaking Non-GLP Pathology Module, a significant enhancement for its renowned Provantis platform. This innovative module is designed to improve the quality and efficiency of in vivo preclinical study management. By leveraging cutting-edge cloud technology, it simplifies the...

Continue Reading